MicroPort NeuroTech (HKG:2172) granted a three-year non-exclusive license to majority shareholder MicroPort Scientific (HKG:0853) to commercialize its medical devices overseas, according to a bourse filing Friday.
MicroPort NeuroTech shares gained nearly 4% in midday trade Monday, while MicroPort Scientific shares rose over 2%.
The agreement runs until June 26, 2028, MicroPort NeuroTech said.